the rate with tysabri(before jcv testing was 1/1000. the rate for rituxan was more like 1/500,000. while this should be monitored, i dont think it will make a big dent in the impact of the drug
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.